Bioanalytical Systems Inc. (BASI)

2.77
0.12 4.50
NASDAQ : Health Services
Prev Close 2.65
Open 2.68
Day Low/High 2.65 / 2.79
52 Wk Low/High 1.18 / 2.65
Volume 66.59K
Avg Volume 14.60K
Exchange NASDAQ
Shares Outstanding 10.50M
Market Cap 25.93M
P/E Ratio N/A
Div & Yield N.A. (N.A)
3 Stocks Driving The Diversified Services Industry Higher

3 Stocks Driving The Diversified Services Industry Higher

TheStreet highlights 3 stocks that pushed the Diversified Services industry

3 Stocks Pushing The Services Sector Lower

3 Stocks Pushing The Services Sector Lower

TheStreet highlights 3 stocks pushing the Services sector lower today.

CORRECTING and REPLACING BASi Reports Third Quarter Net Income of $.03 Per Share

CORRECTING and REPLACING BASi Reports Third Quarter Net Income of $.03 Per Share

In the "Earnings Conference Call" paragraph of the release, the second sentence should read: To participate in the call, dial 866.

3 Stocks Pushing The Services Sector Lower

3 Stocks Pushing The Services Sector Lower

TheStreet highlights 3 stocks pushing the Services sector lower today.

3 Stocks Driving The Diversified Services Industry Higher

3 Stocks Driving The Diversified Services Industry Higher

TheStreet highlights 3 stocks that pushed the Diversified Services industry

3 Stocks Pushing The Diversified Services Industry Lower

3 Stocks Pushing The Diversified Services Industry Lower

TheStreet highlights 3 stocks pushing the Diversified Services industry lower today.

3 Diversified Services Stocks Pushing Industry Growth

3 Diversified Services Stocks Pushing Industry Growth

TheStreet highlights 3 stocks that pushed the Diversified Services industry

3 Stocks Pushing The Diversified Services Industry Lower

3 Stocks Pushing The Diversified Services Industry Lower

TheStreet highlights 3 stocks pushing the Diversified Services industry lower today.

3 Stocks Pushing The Diversified Services Industry Lower

3 Stocks Pushing The Diversified Services Industry Lower

TheStreet highlights 3 stocks pushing the Diversified Services industry lower today.

3 Stocks Pushing The Diversified Services Industry Lower

3 Stocks Pushing The Diversified Services Industry Lower

TheStreet highlights 3 stocks pushing the Diversified Services industry lower today.

BASi Names Jeffrey Potrzebowski CFO And James Bourdage VP Bioanalytical Operations

BASi Names Jeffrey Potrzebowski CFO And James Bourdage VP Bioanalytical Operations

Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced the appointment of Jeffrey Potrzebowski as Chief Financial Officer and James S.

3 Diversified Services Stocks Nudging The Industry Higher

3 Diversified Services Stocks Nudging The Industry Higher

TheStreet highlights 3 stocks that pushed the Diversified Services industry

BASi Hosts In Vivo Drug Discovery Workshop At UCLA

BASi Hosts In Vivo Drug Discovery Workshop At UCLA

Bioanalytical Systems, Inc. (NASDAQ:BASI) announced that it hosted a workshop yesterday at UCLA designed to help academic researchers efficiently navigate the in vivo study process that is the foundation of drug...

BASi Reports Second Quarter Results

BASi Reports Second Quarter Results

Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the second quarter and first six months of fiscal 2014.

3 Stocks Driving The Diversified Services Industry Higher

3 Stocks Driving The Diversified Services Industry Higher

TheStreet highlights 3 stocks that pushed the Diversified Services industry

3 Diversified Services Stocks Pushing Industry Growth

3 Diversified Services Stocks Pushing Industry Growth

TheStreet highlights 3 stocks that pushed the Diversified Services industry

Bioanalytical Systems Inc. Stock Downgraded (BASI)

Bioanalytical Systems Inc. Stock Downgraded (BASI)

Bioanalytical Systems (Nasdaq:BASI) has been downgraded by TheStreet Ratings from from a hold to sell.

Ratings Changes Today

Upgrades: ALTR, COVR, DENN, HLX, INOD, PVA, SLW, TSLA, UCTT Downgrades: BASI, ETE, NOR, TRAK Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

BASi Reports First Quarter Results

BASi Reports First Quarter Results

Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the first quarter of fiscal 2014.

Bioanalytical Systems, Inc. To Present At The 10th Annual Noble Financial Capital Markets Equity Conference Wednesday, January 22, 2014 At 10:00 A.m. EST

Bioanalytical Systems, Inc. To Present At The 10th Annual Noble Financial Capital Markets Equity Conference Wednesday, January 22, 2014 At 10:00 A.m. EST

Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will make a presentation at the Tenth Annual Noble Financial Capital Markets Equity Conference on Wednesday, January 22, 2014 at 10:00 a.

Ratings Changes Today

Upgrades: ACRE, AYR, BASI, FEIM, HOV, III Downgrades: None Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

BASi Reports Profitable Fourth Quarter And Fiscal 2013

BASi Reports Profitable Fourth Quarter And Fiscal 2013

Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the fourth quarter and fiscal 2013, highlighted by net income of $252,000, or $0.

Bioanalytical Systems Reschedules Fourth Quarter & Fiscal 2013 Earnings Release To Tuesday, December 24, 2013; Conference Call & Webcast Set For 11:00 A.m. EST

Bioanalytical Systems Reschedules Fourth Quarter & Fiscal 2013 Earnings Release To Tuesday, December 24, 2013; Conference Call & Webcast Set For 11:00 A.m. EST

Bioanalytical Systems, Inc. (NASDAQ:BASI) has rescheduled the release of financial results for the fourth quarter and fiscal 2013 ended September 30, 2013 to Tuesday, December 24, 2013.

BASi Announces Extension Of Mortgage Maturity

BASi Announces Extension Of Mortgage Maturity

Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it has negotiated a twelve month extension, until October 31, 2014, on the maturity of its $5,255,000 mortgage that was originally scheduled to mature on...

BASi Reports Profitable Third Quarter

BASi Reports Profitable Third Quarter

Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the third quarter and first nine months of fiscal 2013.

BASi Signs Preferred Provider Agreement With G1 Therapeutics.

BASi Signs Preferred Provider Agreement With G1 Therapeutics.

BASi (Bioanalytical Systems, Inc.) (NASDAQ: BASI) announced today that it has entered into a Preferred Provider Agreement (PPA) with G1 Therapeutics, a privately held company that develops small molecule therapeutics...

BASi Files Amended Form 10-K And 10-Q With The SEC

BASi Files Amended Form 10-K And 10-Q With The SEC

Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it has filed amended quarterly and annual reports with the SEC, including Form 10-K/A for the fiscal years ended September 30, 2011 and 2012, Form 10-Q/A...

TheStreet Quant Rating: D+ (Sell)